Reassessing the Benefits and Risks of Alosetron: What is its Place in the Treatment of Irritable Bowel Syndrome?

Author: Andresen V.  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.27, Iss.5, 2004-01, pp. : 283-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract